Article
Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II.
Cancer research - 15 Feb 1994
Shibuya M L, Ueno A M, Vannais D B, Craven P A, Waldren C A
Abstract excerpt
Amsacrine, [4'-(9-acridinylamino)-methanesulfon-m-auisidide], belongs to the class of cancer chemotherapeutic agents that target DNA topoisomerase II. We show that, over its cytotoxic range, amsacrine is a potent mutagen of the S1 phenotype in the AL (human x hamster) hybrid cell line. By contrast, amsacrine induction of the HPRT- phenotype in AL cells is at least two decades less frequent and is not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
